Stock detail
Cormedix (CRMD) stock price, chart, and key data
View Cormedix stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Cormedix
CRMD · XNAS
$7.99
+0.50%
+$0.04
Key metrics
52-week range
$4.25 - $2.00
Close price
$7.96
Market cap
$633.7M
P/E ratio
27.43
Beta
0.76
About the company
Cormedix Inc
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$14.00
3
Buy
/ 3
Recent calls
08/13/2026
RBC Capital
Leonid Timashev
Buy · Price target $14.00
08/14/2026
H.C. Wainwright
Brandon Folkes
Buy · Price target $13.00
08/13/2026
Needham
Serge Belanger
Buy · Price target $15.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
No holder data is available for this category yet.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app